First-line and second-line antiretroviral therapy

被引：4
|
作者：
Calmy, A [1 ]
Pascual, F [1 ]
Ford, N [1 ]
机构：
[1] Med Sans Frontieres, CH-1211 Geneva 21, Switzerland
来源：
LANCET | 2004年 / 364卷 / 9431期
关键词：
D O I：
10.1016/S0140-6736(04)16716-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：329 / 329
页数：1
相关论文
共 50 条
  • [31] Second-line antiretroviral therapy: so much to be done
    Assefa, Yibeltal
    Gilks, Charles F.
    [J]. LANCET HIV, 2017, 4 (10): : E424 - E425
  • [32] Protein binding investigation of first-line and second-line antituberculosis drugs
    Aalhoul, F.
    Fage, D.
    Cotton, F.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (06)
  • [33] Treatment of Primary Biliary Cholangitis First-Line and Second-Line Therapies
    Liu, Chung-Heng
    Bowlus, Christopher L.
    [J]. CLINICS IN LIVER DISEASE, 2022, 26 (04) : 705 - 726
  • [34] Dolutegravir for second-line antiretroviral therapy: the beat goes on
    Shangase, Nosipho
    Kufa, Tendesayi
    [J]. LANCET GLOBAL HEALTH, 2024, 12 (02): : E183 - E184
  • [35] Tenofovir resistance and first-line antiretroviral therapy
    Ford, Nathan
    Vitoria, Marco
    Doherty, Meg
    Bertagnolio, Silvia
    [J]. LANCET INFECTIOUS DISEASES, 2016, 16 (08): : 890 - 891
  • [36] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
    Taubert R.
    Engel B.
    [J]. Die Innere Medizin, 2024, 65 (4) : 325 - 333
  • [37] High levels of drug resistance after failure of first-line antiretroviral therapy in rural South Africa: impact on standardised second-line regimens
    Manasa, J.
    McGrath, N.
    Lessells, R.
    Skingsley, A.
    Newell, M. -L.
    de Oliveira, T.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 38 - 39
  • [38] Limited Impact of First-Line Drug Resistance Mutations on Virologic Response Among Patients Receiving Second-Line Antiretroviral Therapy in Rural Uganda
    Moore, David M.
    Nanfuka, Mastula
    Zhang, Wendy
    Okoboi, Steven
    Kaleebu, Pontiano
    Kapaata, Anne
    Zhu, Julia
    Tibengana, Baker
    Birungi, Josephine
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 92 (01) : 84 - 88
  • [39] Brief communication: The rate of switching from first-line to second-line antiretroviral therapy among people living with HIV in Aden City, Yemen
    Al-Haidary, Naif Mohammed
    Radman, Enas Abobakr
    [J]. AIDS RESEARCH AND THERAPY, 2024, 21 (01):
  • [40] Impact of first-line treatment response on second-line therapy with nintedanib plus docetaxel in advanced lung adenocarcinoma after combined first-line immunochemotherapy
    Grohe, C.
    Wehler, T.
    Henschke, S.
    Dittrich, I
    Hammerschmidt, S.
    Aulmann, C.
    Dechow, T.
    Schiefer, C.
    von der Heyde, E.
    Schuette, W.
    Atz, J.
    Kaiser, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 208 - 208
12345